IMB5036 Inhibits Human Pancreatic Cancer Growth Primarily through Activating Necroptosis

By
Justin.choi
-
0
16
MLKL inhibitor NSA attenuated the killing effect of IMB5036 on pancreatic cancer cells. IMB5036 stimulated translocation of MLKL and p-MLKL from cytoplasm to cell membrane.
[Basic & Clinical Pharmacology & Toxicology]

Sorry, but the selected Zotpress account can't be found.

Abstract